查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654684

全球食道鏡和胃鏡市場 - 2025 至 2033 年

Global Esophagoscopes and Gastroscopes Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 153 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球食道鏡和胃鏡市場規模達到 18 億美元，預計到 2033 年將達到 29 億美元，2025-2033 年預測期內的複合年成長率為 5.6%。

食道鏡是用於檢查食道（連接喉嚨和胃的管道）的專門內視鏡儀器。這些設備用於診斷食道疾病，例如胃酸逆流症 (GERD)、食道癌、食道狹窄和異物取出。食道鏡可以是剛性的，也可以是軟性的，其中軟性食道鏡由於其能夠彎曲並舒適地穿過食道而更常用。

胃鏡是用來檢查胃和小腸上部的內視鏡儀器。這些設備對於診斷和治療胃炎、消化性潰瘍、胃癌和幽門螺旋桿菌感染等疾病至關重要。與食道鏡類似，胃鏡可為硬式或軟式，其中軟式胃鏡因可輕鬆進入胃及十二指腸的各個部位而得到更廣泛的應用。

食道鏡和胃鏡的需求受到多種關鍵因素的推動，包括胃腸道 (GI) 疾病盛行率的不斷上升、內視鏡技術的進步以及醫療保健投資的不斷成長。胃炎、消化性潰瘍、胃食道逆流症 (GERD)、食道癌和胃癌以及其他胃腸道疾病等胃腸道疾病發病率的增加大大增加了對診斷和治療內視鏡手術的需求。例如，在最近一項在33個國家進行的全球研究中，作者發現全世界超過40%的人患有胃腸道疾病，發展中國家的盛行率更高。

市場動態：

促進因素與約束因素

一次性食道鏡和胃鏡的採用率不斷上升

一次性食道鏡和胃鏡的日益普及極大地推動了食道鏡和胃鏡市場的成長，預計將在預測期內推動市場的發展。 COVID-19 疫情提高了人們對醫療保健環境中感染預防的關注，尤其是在交叉污染風險較高的內視鏡檢查過程中。如果沒有正確消毒，可重複使用的食道鏡和胃鏡可能會帶來嚴重的健康風險，包括傳播醫院內感染（HAI）。由於醫院和醫療保健提供者將病患安全放在首位，對一次性食道鏡和胃鏡的偏好日益增加，導致市場採用率不斷成長。

例如，2024 年 7 月，EvoEndo, Inc. 發布了型號 LE 85 一次性胃鏡，為上消化道無鎮靜經鼻內視鏡檢查 (TNE) 提供了另一種選擇。 LE 85 型一次性胃鏡旨在當不需要進入十二指腸時提供最佳的患者舒適度和醫生控制。它的軸長更短，靈活性更高，能夠確保患者的安全。

隨著患者和醫生繼續青睞恢復時間更快、併發症發生率更低的微創手術，一次性內視鏡的需求正在上升。這些設備支援具有下一代功能的各種診斷和治療程序，同時還提供安全性和易用性的額外優勢。這些一次性設備使醫生能夠滿足醫院環境、重症監護室和內視鏡科的更大需求。

例如，2024 年 4 月，Ambu 宣布其治療性胃鏡解決方案 Ambu aScope Gastro Large 和 Ambu aBox 2 已獲得美國食品藥物管理局 (FDA) 的 510(k) 監管批准。擴展的內視鏡產品組合，包括 aScope Gastro 和 aScope Gastro Large，使醫生能夠滿足醫院環境中（例如手術室、重症監護室和內視鏡室）的更多種類的需求。

來自替代診斷技術的競爭

雖然食道鏡和胃鏡對於診斷和治療胃腸道 (GI) 疾病仍然至關重要，但來自替代診斷技術的競爭對市場的成長構成了越來越大的挑戰。這些替代方案通常提供非侵入性、經濟高效且對患者侵入性較小的選擇，可與傳統內視鏡檢查程序相媲美。

CT 掃描 (電腦斷層掃描)、MRI (磁振造影) 和超音波等非侵入性影像技術作為傳統內視鏡手術的替代方案，正日益受到關注。這些影像方法使醫生無需進行侵入性手術即可診斷胃腸道疾病，從而降低了併發症的風險並提高了患者的舒適度。 CT大腸造影（虛擬大腸鏡檢查）由於其手術時間更短、患者不適感更少而越來越受到人們的認可。

膠囊內視鏡檢查是將一個小型相機以藥丸的形式送入患者體內，作為一種檢查小腸的傳統內視鏡檢查的非侵入性替代方法，正越來越受歡迎。這種方法使醫生無需使用食道鏡或胃鏡即可觀察胃腸道，特別是在不明原因的胃腸道出血或小腸疾病的情況下。例如，據美敦力公司稱，膠囊內視鏡市場（如PillCam系統）正在成長，特別是在北美和歐洲等地區。這阻礙了對食道鏡和胃鏡的需求。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 依產品類型分類
  • 可用性片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 一次性食道鏡和胃鏡的普及率不斷上升
    • 限制
      • 來自替代診斷技術的競爭
    • 機會
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • 新興創業公司和關鍵創新者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：食道鏡和胃鏡市場（依產品類型）

  • 食道鏡
    • 硬質食道鏡
    • 軟性食道鏡
    • 經鼻食道鏡
    • 纖維食道鏡
  • 胃鏡
    • 硬式胃鏡
    • 軟性胃鏡
    • 經鼻胃鏡
    • 電子胃鏡

第 6 章：食道鏡和胃鏡市場（按可用性分類）

  • 一次性的
  • 可重複使用的

第 7 章：食道鏡和胃鏡市場（按應用）

  • 食道疾病
  • 胃病
  • 食道癌及胃癌檢測
  • 胃組織切片
  • 食道支架手術
  • 其他

第 8 章：食道鏡和胃鏡市場（按最終用戶分類）

  • 醫院
  • 專科診所
  • 診斷中心
  • 門診手術中心
  • 其他

第 9 章：食道鏡和胃鏡市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • Olympus Corporation
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 關鍵進展
    • SWOT 分析
  • FUJIFILM Holdings Corporation
  • Ambu A/S
  • EvoEndo, Inc.
  • EndoMed Systems GmbH
  • Ottomed Endoscopy
  • KARL STORZ
  • Integra LifeSciences Corporation
  • PENTAX Medical
  • Erbe Elektromedizin GmbH

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MI9130

The global esophagoscopes and gastroscopes market reached US$ 1.8 billion in 2024 and is expected to reach US$ 2.9 billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

Esophagoscopes are specialized endoscopic instruments used to examine the esophagus, which is the tube that connects the throat to the stomach. These devices are utilized for diagnosing esophageal disorders, such as acid reflux disease (GERD), esophageal cancer, esophageal stricture and foreign body removal. Esophagoscopes can be either rigid or flexible, with flexible esophagoscopes being more commonly used due to their ability to bend and navigate the esophagus comfortably.

Gastroscopes are endoscopic instruments used to examine the stomach and the upper part of the small intestine. These devices are crucial for diagnosing and treating conditions such as gastritis, peptic ulcers, gastric cancers, and H. pylori infection. Similar to esophagoscopes, gastroscopes can be rigid or flexible, with flexible gastroscopes being more widely adopted due to their ability to access various parts of the stomach and the duodenum with ease.

The demand for esophagoscopes and gastroscopes is driven by several key factors, including the increasing prevalence of gastrointestinal (GI) disorders, advancements in endoscopic technology and growing healthcare investments. The increased incidence of gastrointestinal diseases such as gastritis, peptic ulcers, gastroesophageal reflux disease (GERD), esophageal and stomach cancers and other GI disorders significantly fuels the demand for diagnostic and therapeutic endoscopic procedures. For instance, in a recent global study conducted in 33 countries, the authors found that more than 40% of people worldwide have gastrointestinal disorders with higher prevalence in developing countries.

Market Dynamics: Drivers & Restraints

Rising adoption of disposable esophagoscopes and gastroscopes

The rising adoption of disposable esophagoscopes and gastroscopes is significantly driving the growth of the esophagoscopes and gastroscopes market and is expected to drive the market over the forecast period. The COVID-19 pandemic heightened the focus on infection prevention within healthcare settings, especially in endoscopic procedures, where the risk of cross-contamination is high. Reusable esophagoscopes and gastroscopes, if not properly sterilized, can pose serious health risks, including the transmission of hospital-acquired infections (HAIs). The rising preference for disposable esophagoscopes and gastroscopes has led to growing market adoption as hospitals and healthcare providers prioritize patient safety.

For instance, in July 2024, EvoEndo, Inc. released the Model LE 85 Single-Use Gastroscope, providing an additional option for Sedation-Free Transnasal Endoscopy (TNE) of the Upper Gastrointestinal Tract. The Model LE 85 Single-Use Gastroscope is intended to provide optimal patient comfort and physician control when access to the duodenum is not necessary. It has a shorter shaft length and more flexibility for patient safety.

As patients and physicians continue to favor minimally invasive procedures that offer faster recovery times and reduced complication rates, the demand for single-use endoscopes is on the rise. These devices support a variety of diagnostic and therapeutic procedures with next-generation features while offering the added benefit of safety and ease of use. These disposable devices enables doctors to address a larger demands in hospital settings, critical care unit and endoscopic unit.

For instance, in April 2024, Ambu announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its therapeutic gastroscope solution, Ambu aScope Gastro Large and Ambu aBox 2. The approval represents an expanded solution offering for surgeons and gastroenterologists who undertake upper GI operations. The expanded endoscope portfolio, including the aScope Gastro and aScope Gastro Large, enables doctors to address a larger variety of demands in hospital settings such as the operating room, critical care unit and endoscopic unit.

Competition from alternative diagnostic technologies

While esophagoscopes and gastroscopes remain crucial for diagnosing and treating gastrointestinal (GI) disorders, the competition from alternative diagnostic technologies is increasingly presenting challenges to the growth of the market. These alternatives often offer non-invasive, cost-effective, and less patient-invasive options that compete with traditional endoscopy procedures.

Non-invasive imaging techniques, such as CT scans (computed tomography), MRI (magnetic resonance imaging) and ultrasound are gaining traction as alternatives to traditional endoscopic procedures. These imaging methods allow physicians to diagnose gastrointestinal conditions without the need for invasive procedures, reducing the risks of complications and improving patient comfort. CT Colonography (Virtual Colonoscopy) is increasingly gaining acceptance due to its shorter procedure time and less patient discomfort.

Capsule endoscopy, where a small camera is ingested by the patient in the form of a pill, is gaining popularity as a non-invasive alternative to traditional endoscopies for examining the small intestine. This method allows physicians to view the GI tract without the need for esophagoscopes or gastroscopes, particularly in cases of obscure GI bleeding or small bowel conditions. For instance, according to Medtronic, the market for capsule endoscopy (e.g., PillCam systems) is growing, particularly in regions like North America and Europe. Which hampers the demand for esophagoscopes and gastroscopes.

Segment Analysis

The global esophagoscopes and gastroscopes market is segmented based on product type, usability, application, end-user and region.

Product Type:

The gastroscopes segment is expected to dominate the esophagoscopes and gastroscopes market share

Gastrointestinal diseases, such as gastritis, peptic ulcers, esophageal varices, gastric cancer and gastroesophageal reflux disease (GERD), have become increasingly common globally. The demand for gastroscopic procedures to diagnose and treat these conditions is significantly higher compared to esophageal disorders, making gastroscopes a dominant segment.

For instance, gastric cancer is one of the most prevalent cancers globally. According to the World Health Organization (WHO), there are over 1 million new cases of gastric cancer diagnosed annually, leading to an increase in gastroscopy procedures. The prevalence of GERD is growing, particularly in Western countries, where the condition affects approximately 20% of the population, driving the demand for gastroscopes for diagnosis and management.

The market for gastroscopes is also dominated by established companies, which continually improve the technology and increase adoption. Major manufacturers are focusing on innovative features, such as high-definition imaging, advanced gastrointestinal endoscopy and single-use gastroscopes, further enhancing the segment's growth. Companies like Olympus Corporation, Pentax Medical, and Fujifilm lead the market with advanced gastroscopes that include high-definition imaging technology for better diagnosis.

For instance, in May 2023, Olympus Corporation announced the FDA clearance of the new EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes: the GIF-1100 gastrointestinal videoscope indicated for use within the upper digestive tract and the CF-HQ1100DL/I colonovideoscope indicated for use within lower digestive tract.

Gastroscopes are commonly used for both diagnostic and therapeutic purposes, which increases their usage frequency. They are not only used to examine the upper GI tract, but also for procedures like biopsy, polyp removal, and stent placement, making them indispensable in modern GI practice. Gastroscopy is a standard procedure for diagnosing gastritis, ulcers, and esophageal cancers. The procedure also plays a critical role in endoscopic ultrasound (EUS) for staging cancers, further solidifying its importance in the medical field.

Geographical Analysis

North America is expected to hold a significant position in the esophagoscopes and gastroscopes market share

North America has one of the highest prevalence rates for esophageal and gastrointestinal diseases, which significantly drives the demand for gastroscopic and esophagoscopic procedures. Conditions like GERD (gastroesophageal reflux disease), gastritis, peptic ulcers, esophageal cancers and irritable bowel syndrome (IBS) are increasingly common, leading to higher utilization of diagnostic procedures involving esophagoscopes and gastroscopes.

For instance, according to the National Institute of Health, GERD affects approximately 20% of the U.S. population. This has led to a growing need for gastroscopies for diagnosis and treatment. Esophageal cancer is also prevalent, with the American Cancer Society estimating that in 2025, about 22,070 new esophageal cancer cases diagnosed (17,430 in men and 4,640 in women) and about 16,250 deaths from esophageal cancer (12,940 in men and 3,310 in women). This further contributes to the high demand for gastroscopic procedures for diagnosis and treatment of associated symptoms.

Leading global players such as Olympus, Medtronic, Pentax Medical and Fujifilm have a strong foothold in the North American market, which supports both the supply and adoption of gastroscopes and esophagoscopes. These companies are focused on innovation and meeting the rising demand for advanced imaging systems, robot-assisted surgeries, and disposable endoscopes.

For instance, Olympus Corporation is one of the largest manufacturers of gastroscopes and esophagoscopes, and the company has a significant market share in North America, driven by the growing demand for high-definition, disposable, and minimally invasive technologies. According to the Olympus Corporation, North American market accounts for about 35% of total sales in the GI endoscopy.

Asia-Pacific is growing at the fastest pace in the esophagoscopes and gastroscopes market

Countries in the Asia Pacific are investing heavily in upgrading their healthcare infrastructure, including the adoption of modern medical technologies such as gastroscopes and esophagoscopes. The development of healthcare facilities and endoscopic centers in both urban and rural areas is improving access to endoscopic diagnostic tools including esophagoscopes and gastroscopes.

For instance, in July 2024, FUJIFILM India launched its second-largest endoscopy equipment service center in Mumbai. The center will handle repairs of gastroscopes and high-end processors. The new facility aims to reduce service turnaround times and improve delivery across India.

With the increasing preference for minimally invasive procedures in Asia Pacific, there is a higher demand for gastroscopic and esophagoscopic procedures, as they offer patients faster recovery times, reduced discomfort and fewer risks compared to traditional surgical methods. For instance, single-use gastroscopes are gaining traction in the region, especially in countries like India and China, where there is a rising demand for affordable, effective diagnostic solutions in hospitals and clinics.

Competitive Landscape

The major global players in the esophagoscopes and gastroscopes market include Olympus Corporation, FUJIFILM Holdings Corporation, Ambu A/S, EvoEndo, Inc., EndoMed Systems GmbH, Ottomed Endoscopy, KARL STORZ, Integra LifeSciences Corporation, PENTAX Medical, Erbe Elektromedizin GmbH and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global esophagoscopes and gastroscopes market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 153 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Usability
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Adoption of Disposable Esophagoscopes and Gastroscopes
    • 3.1.2. Restraints
      • 3.1.2.1. Competition from Alternative Diagnostic Technologies
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Esophagoscopes And Gastroscopes Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Esophagoscopes*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Rigid Esophagoscopes
    • 5.2.4. Flexible Esophagoscopes
    • 5.2.5. Transnasal Esophagoscopes
    • 5.2.6. Fiberoptic Esophagoscopes
  • 5.3. Gastroscopes
    • 5.3.1. Rigid Gastroscopes
    • 5.3.2. Flexible Gastroscopes
    • 5.3.3. Transnasal Gastroscopes
    • 5.3.4. Video Gastroscopes

6. Esophagoscopes And Gastroscopes Market, By Usability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 6.1.2. Market Attractiveness Index, By Usability
  • 6.2. Disposable*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Reusable

7. Esophagoscopes And Gastroscopes Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Esophageal Disorders*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gastric Disorders
  • 7.4. Esophageal and Gastric Cancer Detection
  • 7.5. Gastric Tissue Biopsy
  • 7.6. Esophageal Stent Procedures
  • 7.7. Others

8. Esophagoscopes And Gastroscopes Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Ambulatory Surgical Centers
  • 8.6. Others

9. Esophagoscopes And Gastroscopes Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Olympus Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. FUJIFILM Holdings Corporation
  • 11.3. Ambu A/S
  • 11.4. EvoEndo, Inc.
  • 11.5. EndoMed Systems GmbH
  • 11.6. Ottomed Endoscopy
  • 11.7. KARL STORZ
  • 11.8. Integra LifeSciences Corporation
  • 11.9. PENTAX Medical
  • 11.10. Erbe Elektromedizin GmbH

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us